ELISA, protein immunoprecipitation and line blot assays for anti-TIF1-gamma autoantibody detection in cancer-associated dermatomyositis.

MLA

Selickaja, Sandra, et al. “ELISA, Protein Immunoprecipitation and Line Blot Assays for Anti-TIF1-Gamma Autoantibody Detection in Cancer-Associated Dermatomyositis.” Rheumatology (Oxford, England), vol. 61, no. 12, Nov. 2022, pp. 4991–96. EBSCOhost, https://doi.org/10.1093/rheumatology/keac288.

APA

Selickaja, S., Galindo-Feria, A. S., Dani, L., Mimori, T., Rönnelid, J., Holmqvist, M., Lundberg, I. E., & Venalis, P. (2022). ELISA, protein immunoprecipitation and line blot assays for anti-TIF1-gamma autoantibody detection in cancer-associated dermatomyositis. Rheumatology (Oxford, England), 61(12), 4991–4996. https://doi.org/10.1093/rheumatology/keac288

Chicago

Selickaja, Sandra, Angeles S Galindo-Feria, Lara Dani, Tsuneyo Mimori, Johan Rönnelid, Marie Holmqvist, Ingrid E Lundberg, and Paulius Venalis. 2022. “ELISA, Protein Immunoprecipitation and Line Blot Assays for Anti-TIF1-Gamma Autoantibody Detection in Cancer-Associated Dermatomyositis.” Rheumatology (Oxford, England) 61 (12): 4991–96. doi:10.1093/rheumatology/keac288.